Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Llewelyn J. Rao
Observed names:
Llewelyn J Rao,
Llewelyn Rao,
Rao, Llewelyn J.
Institution:
Regeneron (United States)
Observed institutions:
New York Medical College,
Regeneron (United States),
New York Eye and Ear Infirmary,
Retina Associates of Kentucky,
Retina Associates of Florida,
Tennessee Retina,
Case Western Reserve University
show all 7
OpenAlex ID:
A5113985388
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
2023
·
Jeffrey S Heier
, Eleonora M Lad
, et al.
·
The Lancet
·
585
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2024
·
David M Brown
, David S Boyer
, et al.
·
The Lancet
·
174
PDF
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
2018
·
Lee M. Jampol
, Adam R. Glassman
, et al.
·
Ophthalmology
·
44
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical Trial
2021
·
Maureen G. Maguire
, Danni Liu
, et al.
·
JAMA Ophthalmology
·
33
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration
2023
·
Joseph M. Coney
, Ryan Zubricky
, et al.
·
International Journal of Retina and Vitreous
·
18
PDF
RECURRENT HEMOLACRIA: A Sign of Scleral Buckle Infection
2010
·
Krishna Mukkamala
, Ronald C Gentile
, et al.
·
Retina
·
15
Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial
2021
·
Ahmad A. Aref
, Ingrid U. Scott
, et al.
·
JAMA Ophthalmology
·
14
Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial
2023
·
Steven M. Kymes
, Neal L. Oden
, et al.
·
JAMA Ophthalmology
·
10
Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18
2022
·
Ingrid U. Scott
, Neal L. Oden
, et al.
·
JAMA Ophthalmology
·
7
Effect of Regulatory Requirement for Patient-Specific Prescriptions for Off-Label Medications on the Use of Intravitreal Bevacizumab
2015
·
Steven Holfinger
, Alexander G. Miller
, et al.
·
JAMA Ophthalmology
·
6
PDF
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents
2023
·
Joseph Coney
, Jasmyne McCoy
, et al.
·
Clinical ophthalmology
·
2
PDF
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial
2025
·
Kiyoshi Suzuma
, Toshinori Murata
, et al.
·
Japanese Journal of Ophthalmology
·
1
PDF
Incidence of Recurrent Choroidal Neovascularization Following Treatment with Pegcetacoplan for Geographic Atrophy in Exudative Age-Related Macular Degeneration Patients with Inactive Choroidal Neovascularization
2025
·
Ryan Zubricky
, Chase Miller
, et al.
·
Archives of Ophthalmology and Optometry
·
1
PDF
Surgical Outcomes and Patient Satisfaction in Vitrectomy for Vitreous Floaters
2019
·
Charles Pophal
, Rohit Chandra
, et al.
·
Investigative Ophthalmology & Visual Science
·
1
Fluocinolone acetonide (FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)
2018
·
John Liu
, Joseph Coney
, et al.
·
Investigative Ophthalmology & Visual Science
·
1
First-Year Fellow Single Surgery Success Rate in Primary Rhegmatogenous Retinal Detachments
2025
·
Ryan Zubricky
, Harrison Sciulli
, et al.
·
Archives of Ophthalmology and Optometry
PDF
Thermal Laser and Photodynamic Therapy
2024
·
Llewelyn J. Rao
, Lawrence J. Singerman
·
CRC Press eBooks
Frequency and symptoms of intravitreal silicone oil droplets following bevacizumab injections from BD insulin syringes
2020
·
David Miller
, Chase Miller
, et al.
·
Investigative Ophthalmology & Visual Science
Efficacy of the 0.19 mg Fluocinolone Acetonide (FAc) Implant (ILUVIEN®) in a Multiphysician, Single-practice Setting – The Cleveland Experience
2019
·
Daniel C Daroszewski
, Joseph Coney
, et al.
·
Investigative Ophthalmology & Visual Science
Retinal Surgery in Ambulatory Surgery Centers versus Hospital Outpatient Departments
2017
·
Harrison Sciulli
, Chase W. Miller
, et al.
·
Ophthalmology Retina
Incindences of Endophthalmitis in Various Anti-VEGF Treatments
2016
·
Mahdi Rostamizadeh
, Musa Abdelaziz
, et al.
·
Investigative Ophthalmology & Visual Science
Retinal Surgery Case Selection and Safety in an Ambulatory Surgery Center versus Hospital
2016
·
Chase Miller
, Llewelyn Rao
, et al.
·
Investigative Ophthalmology & Visual Science
Long-Term Follow-Up Study on the Natural Progression of Lamellar Macular Holes
2014
·
Jessica Lee
, Rahul Mandiga
, et al.
·
Investigative Ophthalmology & Visual Science
The Effect of Requiring Patient-specific Prescriptions on the Utilization of Intravitreal Bevacizumab.
2014
·
Alexander Miller
, Llewelyn Rao
, et al.
·
Investigative Ophthalmology & Visual Science
Show more works
View as search
Works count:
30
Citation count:
912
H-index:
8
I10-index:
8
Year
Topic
Type